A link between autoimmunity and improved antitumor immunity has long been recognized, although the exact mechanistic relationship between these two phenomena remains unclear. In the present study we have found that vitiligo, the autoimmune destruction of melanocytes, generates self antigen required for mounting persistent and protective memory CD8+ T cell responses to melanoma. Vitiligo developed in approximately 60% of mice that were depleted of regulatory CD4+ T cells and then subjected to surgical excision of large established B16 melanomas. Mice with vitiligo generated 10-fold larger populations of CD8+ memory T cells specific for shared melanoma/melanocyte antigens. CD8+ T cells in mice with vitiligo acquired phenotypic and functional characteristics of effector memory, suggesting that they were supported by ongoing antigen stimulation. Such responses were not generated in melanocyte-deficient mice, indicating a requirement for melanocyte destruction in maintaining CD8+ T cell immunity to melanoma. Vitiligo-associated memory CD8+ T cells provided durable tumor protection, were capable of mounting a rapid recall response to melanoma, and did not demonstrate phenotypic or functional signs of exhaustion even after many months of exposure to antigen. This work establishes melanocyte destruction as a key determinant of lasting melanoma-reactive immune responses, thus illustrating that immune-mediated destruction of normal tissues can perpetuate adaptive immune responses to cancer.
Katelyn T. Byrne, Anik L. Côté, Peisheng Zhang, Shannon M. Steinberg, Yanxia Guo, Rameeza Allie, Weijun Zhang, Marc S. Ernstoff, Edward J. Usherwood, Mary Jo Turk
Title and authors | Publication | Year |
---|---|---|
Cancer therapy via neoepitope-specific monoclonal antibody cocktails
Hartman CJ, Mohamed AO, Shukla GS, Pero SC, Sun YJ, Rodríguez-Jimenez RS, Genovese NF, Kohler NM, Hemphill TR, Huang YH, Krag DN, Ackerman ME |
Cancer Immunology, Immunotherapy : CII | 2025 |
CD39 is expressed on functional effector and tissue resident memory CD8+ T cells
Isaacs JF, Degefu HN, Chen T, Kleist SA, Musial SC, Ford MA, Searles TG, Lin CC, Skorput AG, Shirai K, Turk MJ, Zanazzi GJ, Rosato PC |
Journal of immunology (Baltimore, Md. : 1950) | 2024 |
Cancer therapy-induced dermatotoxicity as a window to understanding skin immunity
Jiménez-Andrade Y, Flesher JL, Park JM |
Hematology/oncology clinics of North America | 2024 |
Depletion of conventional CD4(+) T cells is required for robust priming and dissemination of tumor antigen-specific CD8(+) T cells in the setting of anti-CD4 therapy.
Ramirez DE, Dragnev CPC, Searles TG, Spicer N, Chen T, Lines JL, Hawkes AR, Davis WL, Mohamed A, Shirai K, Phillips JD, Rosato PC, Huang YH, Turk MJ |
Journal for immunotherapy of cancer | 2024 |
Challenges faced when identifying patients for combination immunotherapy
Ernstoff MS, Gandhi S, Pandey M, Puzanov I, Grivas P, Montero A, Velcheti V, Turk MJ, Diaz-Montero CM, Lewis LD, Morrison C |
Future Oncology | 2024 |
Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
Liu D, Yang F, Zhang T, Mao R |
Journal of Translational Medicine | 2023 |
Transient regulatory-T-cell interruption promotes skin-resident memory T cells mediated tumor protection.
Zhao S, Wu S, Jiang S, Zhou X, Zhao G, Wang B |
Scientific Reports | 2023 |
The evolving role of tissue-resident memory T cells in infections and cancer.
Yenyuwadee S, Sanchez-Trincado Lopez JL, Shah R, Rosato PC, Boussiotis VA |
Science Advances | 2022 |
A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte
Chen D, Xu Z, Cui J, Chen T |
Cell Regeneration | 2022 |
Clinical significance and immune landscape of KIR2DL4 and the senescence‐based signature in cutaneous melanoma
Mao R, Ren Z, Yang F, Yang P, Zhang T |
Cancer Science | 2022 |
Cutaneous adverse events in patients treated with PD-1/PD-L1 checkpoint inhibitors and their association with survival: a systematic review and meta-analysis.
Zhao F, Zhu J, Yu R, Shao T, Chen S, Zhang G, Shu Q |
Scientific Reports | 2022 |
Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice
Kim SH, Go EM, Shin DH, Choi BK, Han C |
Cells | 2022 |
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma
J Paillet, C Plantureux, S Lévesque, JL Naour, G Stoll, A Sauvat, P Caudana, JT Boari, N Bloy, S Lachkar, I Martins, P Opolon, A Checcoli, A Delaune, N Robil, P de la Grange, J Hamroune, F Letourneur, G Autret, PS Leung, ME Gershwin, JS Zhu, MJ Kurth, B Lekbaby, J Augustin, Y Kim, S Gujar, C Coulouarn, L Fouassier, L Zitvogel, E Piaggio, C Housset, P Soussan, MC Maiuri, G Kroemer, JG Pol |
Journal of Experimental Medicine | 2021 |
Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cells
SH Kim, E Cho, YI Kim, C Han, BK Choi, BS Kwon |
Nature Communications | 2021 |
Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity
JL Collier, SA Weiss, KE Pauken, DR Sen, AH Sharpe |
Nature Immunology | 2021 |
Dendritic cells maintain anti-tumor immunity by positioning CD8 skin-resident memory T cells
JL Vella, A Molodtsov, CV Angeles, BR Branchini, MJ Turk, YH Huang |
Life science alliance | 2021 |
CD8+ T cell self-tolerance permits responsiveness but limits tissue damage
Truckenbrod EN, Burrack KS, Knutson TP, Borges da Silva H, Block KE, O'Flanagan SD, Stagliano KR, Hurwitz AA, Fulton RB, Renkema KR, Jameson SC |
eLife | 2021 |
Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma.
Molodtsov AK, Khatwani N, Vella JL, Lewis KA, Zhao Y, Han J, Sullivan DE, Searles TG, Preiss NK, Shabaneh TB, Zhang P, Hawkes AR, Malik BT, Kolling FW 4th, Usherwood EJ, Wong SL, Phillips JD, Shirai K, Angeles CV, Yan S, Curiel TJ, Huang YH, Cheng C, Turk MJ |
Immunity | 2021 |
Neuropilin-1 is a T cell memory checkpoint limiting long-term anti-tumor immunity
Liu C, Somasundaram A, Manne S, Gocher AM, Szymczak-Workman AL, Vignali KM, Scott EN, Normolle DP, Wherry EJ, Lipson EJ, Ferris RL, Bruno TC, Workman CJ, Vignali DA |
Nature Immunology | 2020 |
Liposomal gp100 vaccine combined with CpG ODN sensitizes established B16F10 melanoma tumors to anti PD-1 therapy
Yazdani M, Hatamipour M, Alani B, Nikzad H, Mohamadian Roshan N, Verdi J, Jaafari MR, Noureddini M, Badiee A |
Iranian Journal of Basic Medical Sciences | 2020 |
Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
RAMONDETTA A, RIBERO S, CONTI L, FAVA P, MARRA E, BROGANELLI P, CALIENDO V, PICCIOTTO F, GUIDA M, FIERRO MT, QUAGLINO P |
Acta Dermato Venereologica | 2020 |
Skin‐resident memory T cells as a potential new therapeutic target in vitiligo and melanoma
M Willemsen, R Linkutė, RM Luiten, TR Matos |
Pigment Cell & Melanoma Research | 2019 |
Melanoma and Vitiligo: In Good Company
CM Failla, ML Carbone, C Fortes, G Pagnanelli, S DAtri |
International journal of molecular sciences | 2019 |
Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity
A Molodtsov, MJ Turk |
Frontiers in immunology | 2018 |
Resident memory T cells in the skin mediate durable immunity to melanoma
BT Malik, KT Byrne, JL Vella, P Zhang, TB Shabaneh, SM Steinberg, AK Molodtsov, JS Bowers, CV Angeles, CM Paulos, YH Huang, MJ Turk |
Science Immunology | 2017 |
Optimizing T-cell receptor gene therapy for hematologic malignancies
EC Morris, HJ Stauss |
Blood | 2016 |
Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin
J Klarquist, JM Eby, SW Henning, M Li, DA Wainwright, W Westerhof, RM Luiten, MI Nishimura, IC le Poole |
Pigment Cell & Melanoma Research | 2016 |
Human T Cell Crosstalk Is Induced by Tumor Membrane Transfer
R Uzana, G Eisenberg, S Merims, S Frankenburg, A Pato, E Yefenof, R Engelstein, T Peretz, A Machlenkin, M Lotem |
PloS one | 2015 |
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
M Freeman-Keller, Y Kim, H Cronin, A Richards, G Gibney, JS Weber |
Clinical cancer research | 2015 |
Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapies
J Liu, SJ Blake, MJ Smyth, MW Teng |
IBMS BoneKEy | 2014 |
Global Inhibition of DC Priming Capacity in the Spleen of Self-Antigen Vaccinated Mice Requires IL-10
DM Marvel, OJ Finn |
Frontiers in immunology | 2014 |
Autoimmune Vitiligo Does Not Require the Ongoing Priming of Naive CD8 T Cells for Disease Progression or Associated Protection against Melanoma
KT Byrne, P Zhang, SM Steinberg, MJ Turk |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells
A Pommier, A Audemard, A Durand, R Lengagne, A Delpoux, B Martin, L Douguet, AL Campion, M Kato, MF Avril, C Auffray, B Lucas, A Prévost-Blondel |
Proceedings of the National Academy of Sciences | 2013 |
The delicate balance of melanoma immunotherapy
DE Gyorki, M Callahan, JD Wolchok, CE Ariyan |
IBMS BoneKEy | 2013 |
Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity
B Kwong, SA Gai, J Elkhader, KD Wittrup, DJ Irvine |
Cancer research | 2013 |
Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer
DC Binder, B Engels, A Arina, P Yu, JM Slauch, YX Fu, T Karrison, B Burnette, C Idel, M Zhao, RM Hoffman, DH Munn, DA Rowley, H Schreiber |
Cancer immunology research | 2013 |
A central role for inducible heat-shock protein 70 in autoimmune vitiligo
JA Mosenson, JM Eby, C Hernandez, IC le Poole |
Experimental Dermatology | 2013 |
Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma
M Muccioli, C Longstaff, F Benencia |
Immunotherapy | 2012 |
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge
JR Baird, KT Byrne, PH Lizotte, S Toraya-Brown, UK Scarlett, MP Alexander, MR Sheen, BA Fox, DJ Bzik, M Bosenberg, DW Mullins, MJ Turk, S Fiering |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Protective CD8 Memory T Cell Responses to Mouse Melanoma Are Generated in the Absence of CD4 T Cell Help
AL Côté, KT Byrne, SM Steinberg, P Zhang, MJ Turk |
PloS one | 2011 |
New perspectives on the role of vitiligo in immune responses to melanoma.
Byrne KT, Turk MJ |
Oncotarget | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |